Current status of the adjuvant therapy in uterine sarcoma: A literature review

Uterine sarcomas (US) are rare mesenchymal tumours accounting approximately for 3%–7% of all uterine cancers. Histologically, US are classified into mesenchymal tumours or mixed epithelial and mesenchymal tumours. The group of mesenchymal tumours includes uterine leiomyosarcoma (uLMS, 65% of cases),...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzo, Alessandro, Pantaleo, Maria Abbondanza, Saponara, Maristella, Nannini, Margherita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692269/
https://www.ncbi.nlm.nih.gov/pubmed/31417921
http://dx.doi.org/10.12998/wjcc.v7.i14.1753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692269/
https://www.ncbi.nlm.nih.gov/pubmed/31417921
http://dx.doi.org/10.12998/wjcc.v7.i14.1753

Ejemplares similares